tradingkey.logo
tradingkey.logo
Search

Pulse Biosciences Inc

PLSE
Add to Watchlist
28.450USD
+0.945+3.44%
Close 06/26, 16:00ETQuotes delayed by 15 min
1.97BMarket Cap
LossP/E TTM

Earnings Forecast

Currency: USD Updated: 2026-06-26
Previous score
8.67
Change
0
The current earnings forecast score of Pulse Biosciences Inc is 8.67, ranking 16 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 22.00, with a high of 22.00 and a low of 22.00.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
30.667
Target Price
+11.49%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

96
Total
4
Median
6
Average
Company name
Ratings
Analysts
Pulse Biosciences Inc
PLSE
3
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
19

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

What is Pulse Biosciences Inc's expected revenue for the next quarter?

Pulse Biosciences Inc's expected revenue is 533.33K.

What is Pulse Biosciences Inc's price target?

Analysts forecast that Pulse Biosciences Inc's price target is USD 22.00, with the highest forecast at USD 22.00 and the lowest forecast at USD 22.00.

How have Pulse Biosciences IncPLSE's recent earnings per share performed?

The market expectation was USD -0.27, while Pulse Biosciences IncPLSE's earnings per share (EPS) for the previous quarter was USD -0.26. EPS for the next quarter is expected at USD -0.36.

What is the analyst rating for Pulse Biosciences Inc?

Based on the ratings of Pulse Biosciences Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
KeyAI